(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | 18.57%463.33M | 21.99%862.25M | 18.11%390.76M | 19.06%706.82M | --330.83M | 24.45%593.66M | --477.04M |
Operating income | 18.57%463.33M | 21.99%862.25M | 18.11%390.76M | 19.06%706.82M | 330.83M | 24.45%593.66M | 477.04M |
Cost of sales | -17.50%-393.69M | -22.84%-744.21M | -18.41%-335.04M | -19.39%-605.82M | ---282.95M | -23.01%-507.43M | ---412.52M |
Operating expenses | -17.50%-393.69M | -22.84%-744.21M | -18.41%-335.04M | -19.39%-605.82M | -282.95M | -23.01%-507.43M | -412.52M |
Gross profit | 25.00%69.65M | 16.87%118.04M | 16.36%55.71M | 17.13%101M | 47.88M | 33.65%86.23M | 64.51M |
Administrative expenses | -18.08%-29.21M | -6.41%-53.14M | -0.35%-24.73M | -2.50%-49.94M | ---24.65M | -22.76%-48.72M | ---39.69M |
Research and development expenses | ---215K | ---191K | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | -311.44%-2.66M | 25.37%-3.87M | 88.49%-647K | -346.39%-5.19M | ---5.62M | -340.58%-1.16M | --483K |
-Other impairment is provision | -311.44%-2.66M | 25.37%-3.87M | 88.49%-647K | -346.39%-5.19M | ---5.62M | -340.58%-1.16M | --483K |
Special items of operating profit | 22.98%1.23M | -10.46%3.83M | -52.31%1M | -21.26%4.28M | --2.1M | -67.43%5.44M | --16.69M |
Operating profit | 23.80%38.79M | 28.94%64.67M | 58.98%31.33M | 20.04%50.15M | 19.71M | -0.53%41.78M | 42M |
Financing cost | 9.05%-633K | 14.76%-1.5M | 8.66%-696K | 39.34%-1.76M | ---762K | 65.46%-2.89M | ---8.38M |
Earning before tax | 24.55%38.16M | 30.53%63.17M | 61.70%30.64M | 24.46%48.4M | 18.95M | 15.64%38.89M | 33.63M |
Tax | -32.00%-7.16M | -10.91%-12.16M | -70.61%-5.42M | -41.75%-10.96M | ---3.18M | -10.54%-7.73M | ---7M |
After-tax profit from continuing operations | 22.95%31M | 36.27%51.02M | 59.90%25.22M | 20.17%37.44M | 15.77M | 16.98%31.16M | 26.63M |
Earning after tax | 22.95%31M | 36.27%51.02M | 59.90%25.22M | 20.17%37.44M | 15.77M | 16.98%31.16M | 26.63M |
Minority profit | 168.69%1.33M | 2,183.87%1.29M | 214.32%495K | 93.99%-62K | ---433K | ---1.03M | ---- |
Profit attributable to shareholders | 20.03%29.67M | 32.60%49.73M | 52.57%24.72M | 16.51%37.5M | 16.2M | 20.86%32.19M | 26.63M |
Basic earnings per share | 20.41%0.59 | 25.47%0.995 | 34.25%0.49 | 5.17%0.793 | 0.365 | 21.03%0.754 | 0.623 |
Diluted earnings per share | 20.41%0.59 | 25.47%0.995 | 34.25%0.49 | 5.17%0.793 | 0.365 | 21.03%0.754 | 0.623 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data